Exponent, Inc. (NASDAQ:EXPO) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting, IR Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Jasper Bibb - Truist Andrew Nicholas - William Blair Josh Chan - UBS Operator Good day and welcome to the Exponent, Inc. First Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode. [Operator Instructions] Please note, this even ...

Exponent (EXPO) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.33%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.40 per share when it actually produced earnings of $0.46, delivering a surprise of 15%.Over the last ...

Exponent (EXPO) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good day, and welcome to the Exponent, Inc. First Quarter twenty twenty five Earnings Conference Call. All participants will be in the listen only mode. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on your telephone keypad. To withdraw your question, please press then 2. Please note this event is being recorded. I would now like to turn the conference over to Jon ...

EXHIBIT 99.1 Exponent Reports First Quarter 2025 Financial Results MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. "Exponent's first quarter results exceeded expectations, reinforcing both the resilience of our diversified business model and the value we deliver," said Dr. Catherine Corrigan, President and Chief Executive Officer. "Our failure analysis expertise drove increased ...

MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025 to all common stockholders of record as of June 6, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are ...

MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. “Exponent’s first quarter results exceeded expectations, reinforcing both the resilience of our diversified business model and the value we deliver,” said Dr. Catherine Corrigan, President and Chief Executive Officer. “Our failure analysis expertise drove increased dispute-related activities in the chemicals, transportation and uti ...

MENLO PARK, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2025 financial results for the period ended April 4, 2025 following the close of the market on Thursday, May 1, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Comp ...

Exponent Inc. (NASDAQ: EXPO ) is a little-followed consulting company. That said, it is a market leader and has consistently grown in the past decade. Consulting for safety, litigation, regulation, accidents, and failures is a unique business that grows with time. The dividend yield is low, the dividendI am a self-taught individual investor and I have been investing in stocks for over 25 years. I focus on dividend growth investing with a long-term horizon since I believe in the compounding power of dividend ...

Financial Performance - Revenues for 2024 increased by 4.1% to $558,514,000 compared to $536,766,000 in 2023[167] - Net income rose by 9% to $109,002,000 in 2024, up from $100,339,000 in 2023, with diluted earnings per share increasing to $2.11 from $1.94[162] - Total operating income increased to $119,557,000 in 2024, up 7.4% from $111,322,000 in 2023[176] - Other income increased by 13.2% to $27,813,000, primarily due to a $2,851,000 rise in interest income from cash and cash equivalents[178] - EBITDA for 2024 was $147,058,000, representing 28.4% of revenues before reimbursements, up from 27.7% in 2023[191] - Effective tax rate decreased to 26.0% in 2024 from 26.2% in 2023, with an adjusted rate of 27.9% excluding excess tax benefits[179] Segment Performance - Engineering and Other Scientific segment revenues increased by 5.1% to $469,544,000, accounting for 84.1% of total revenues[167] - Environmental and Health segment revenues decreased by 1.0% to $88,970,000, representing 15.9% of total revenues[167] - Engineering and Other Scientific segment operating income rose by 7.1% to $164,883,000, driven by increased billing rates and billable hours[176] Expenses - Compensation and related expenses increased by 3.2% to $330,011,000, constituting 59.1% of total revenues[170] - Other operating expenses rose by 11.2% to $46,196,000, making up 8.3% of total revenues[172] - General and administrative expenses decreased by 7.0% to $22,726,000, representing 4.1% of total revenues[174] Utilization and Operations - Utilization rate improved to 73% in 2024 from 69% in 2023, driven by better alignment of resources with demand[166] - Billable hours remained constant at 1,495,000 for both 2024 and 2023, with a slight increase in utilization[166] - Utilization rate improved to 73% in 2024, up from 69% in 2023, reflecting increased demand for services[192] Cash Flow and Investments - Net cash provided by operating activities was $144,537,000 in 2024, compared to $127,352,000 in 2023[181] - Cash and cash equivalents increased to $258,901,000 as of January 3, 2025, from $187,150,000 at December 29, 2023[181] - The company plans to continue investing in capital expenditures and may use cash reserves for stock repurchases and strategic acquisitions[186] Strategic Focus - The company continues to focus on expanding client relationships and enhancing its capabilities in response to increasing demand for multidisciplinary services[161] Foreign Currency Exposure - The company has net assets of approximately $24.2 million in British Pounds, indicating exposure to foreign currency risk[196]

Exponent, Inc. (NASDAQ:EXPO) Q4 2024 Earnings Conference Call February 6, 2024 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Andrew Nicholas - William Blair Tobey Sommer - Truist Josh Chan - UBS Operator Good day, and welcome to the Exponent, Inc. Q4 2024 Earnings Conference Call. Please note this event is being recorded. I would now like to turn the conference over to Joni Konstante ...